| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Bhavnagri Veer is a General Counsel at Allogene Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 10,000 | $32.05 | $320,517.36 | -1.2% | -32.9% | -74.9% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 16,623 | $37.95 | $630,798.37 | -1.4% | -35.0% | -80.0% | |
| Oct 6, 2020 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 10,000 | $40.00 | $400,000.00 | -2.7% | - | - | |
| Oct 1, 2020 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 25,000 | $36.52 | $912,912.73 | -2.3% | - | - | |
| Sep 1, 2020 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 25,000 | $35.36 | $883,966.00 | -3.4% | - | - | |
| Aug 3, 2020 | ALLO Allogene Therapeutics, Inc. | General Counsel | Sale+OE | 31,553 | $36.89 | $1,164,120.81 | -4.2% | - | - |